United States Pharmaceuticals

Scienture Holdings Inc (SCNX)

Track

The most recent insider trading activity occurred on August 25, 2022, with a BUY transaction by Donald G. Fell. Prior to this, significant BUY transactions were made by CEO Surendra K. Ajjarapu and Donald G. Fell in May 2022. Earlier transactions in 2020 and 2021 involved PLANNED_SALE filings by several executives.
Stock chart
Ticker: SCNX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Fell Donald G.
1 purchase — total 1,620 USD
Buy 25 Aug 2022
Value US$2,554,110.78 | Price 255.38 | Shares 89,748
Buy 20 May 2022
Value US$2,880,880.68 | Price 413.21 | Shares 7,188
Buy 12 May 2022
Value US$2,520.00 | Price 1.26 | Shares 2,000
Planned sale 21 Jun 2021
Value US$4,005.00 | Price 4.45 | Shares 900
Planned sale 19 Apr 2021
Value US$4,212.00 | Price 4.68 | Shares 900
Planned sale 14 Dec 2020
Value US$4,240.00 | Price 5.30 | Shares 800
Planned sale 14 Dec 2020
Value US$39,702.75 | Price 5.29 | Shares 7,500
Planned sale 14 Dec 2020
Value US$9,460.08 | Price 5.26 | Shares 1,800
Planned sale 14 Dec 2020
Value US$2,650.00 | Price 5.30 | Shares 500
Planned sale 14 Jul 2020
Value US$38,080.00 | Price 5.44 | Shares 7,000
Planned sale 13 Jul 2020
Value US$2,855.00 | Price 5.71 | Shares 500
Sale 15 Nov 2017
Value US$28,125,000,000.00 | Price 112,500.00 | Shares 250,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-29 2022-08-25 B Purchase
2.5
Fell Donald G.
Non-Executive Director
89,748 +14.9%
255.38
US$2,554,111 		89,748 +14.9% 255.38 US$2,554,111
2022-05-23 2022-05-20 B Purchase
AJJARAPU SURENDRA K

CEO

Executive Director Large shareholder
7,188 +33.6%
413.21
US$2,880,881 		7,188 +33.6% 413.21 US$2,880,881
2022-05-18 2022-05-12 B Purchase
2.5
Fell Donald G.
Non-Executive Director
62,325 +42.3%
451.13
US$226,417 		62,325 +42.3% 451.13 US$226,417
2021-06-22 2021-06-21 PlS Planned sale
PETERSON MICHAEL L
900 -14.3%
4.45
US$4,005 		900 -14.3% 4.45 US$4,005
2021-04-20 2021-04-19 PlS Planned sale
PETERSON MICHAEL L
Non-Executive Director
900 -12.5%
4.68
US$4,212 		900 -12.5% 4.68 US$4,212
2020-12-16 2020-12-14 PlS Planned sale
Tenaerts Pamela
Non-Executive Director
800 -8.9%
5.30
US$4,240 		800 -8.9% 5.30 US$4,240
2020-12-16 2020-12-14 PlS Planned sale
Patel Prashant

President

Executive Director Large shareholder
7,500 -0.6%
5.29
US$39,703 		7,500 -0.6% 5.29 US$39,703
2020-12-15 2020-12-14 PlS Planned sale
PETERSON MICHAEL L
Non-Executive Director
1,800 -20.0%
5.26
US$9,460 		1,800 -20.0% 5.26 US$9,460
2020-12-15 2020-12-14 PlS Planned sale
2.5
Fell Donald G.
Non-Executive Director
500 -5.6%
5.30
US$2,650 		500 -5.6% 5.30 US$2,650
2020-07-21 2020-07-14 PlS Planned sale
Patel Prashant

President

Executive Director Large shareholder
7,000 -0.5%
5.44
US$38,080 		7,000 -0.5% 5.44 US$38,080
2020-07-21 2020-07-13 PlS Planned sale
Patel Prashant

President

Executive Director Large shareholder
500 -0.0%
5.71
US$2,855 		500 -0.0% 5.71 US$2,855
2018-02-12 2017-11-15 S Sale AJJARAPU SURENDRA K

CEO

Executive Director Large shareholder
250,000 -1.8%
112,500.00
US$28,125,000,000 		250,000 -1.8% 112,500.00 US$28,125,000,000
Explore more

More insider trading research around Scienture Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America